FDA Inspection 976256 — Celgene Corporation D.B.A. Abraxis Bioscience

Celgene Corporation D.B.A. Abraxis Bioscience — FEI 3006814957

The FDA completed an inspection of Celgene Corporation D.B.A. Abraxis Bioscience on Jun 30, 2016 in Melrose Park, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.